Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov kws tshaj lij thiab cov neeg muag khoom ntawm dypyridamole丨cas 58-32-2 hauv Suav teb. Txais tos rau kev lag luam wholesale kev cai ua cov khoom lag luam ntawm tus nqi sib tw los ntawm peb lub hoobkas. Rau cov khoom pheej yig dua, tiv tauj peb tam sim no.
Specifications
| Qib | EP 11.0 |
| Qhov tshwm sim | Ci daj, crystalline hmoov |
| Assay (ntawm qhuav hauv paus) | 98.5 ~ 101.5% |
| Solubility | Xyaum insoluble hauv dej, dawb do soluble nyob rau hauv acetone, soluble nyob rau hauv anhydrous ethanol, dawb do soluble nyob rau hauv diluted hydrochloric acid |
| Kev txheeb xyuas | IR |
| Sulfated tshauv | 0.1% max |
| impurity A | 0.5% max |
| Impurity B | 0.5% max |
| Cov impurity C | 0.5% max |
| Impurity D | 0.2% max |
| Impurity E | 0.2% max |
| Lwm yam tsis paub impurity | 0.1% max |
| Tag nrho impurities | 1.0% max |
| Methanol (Residual kuab tshuaj) | 0.2% max |
| Ethanol (Residual kuab tshuaj) | 0.2% max |
| Benzenesulfonate esters | 3.75 ppm max |
| Chlorides | 200 ppm max |
| Poob rau ziab | 0.5% max |
Daim ntawv thov
Dypyridamole yog ib qho tshuaj siv dav siv hauv kev tshawb fawb plawv, kev kho mob, thiab kev tsim tshuaj. Nws yog feem ntau siv los ua ib qho platelet aggregation inhibitor, txhawb kev tiv thaiv cov xwm txheej thromboembolic xws li mob stroke thiab myocardial infarction. Hauv kev tshawb fawb soj ntsuam, dypyridamole yog siv hauv kev sib xyaw ua ke los txhim kho cov nyhuv antiplatelet thiab txhim kho cov ntshav khiav hauv cov neeg mob uas muaj kab mob plawv. Nws kuj tseem ua haujlwm ua vasodilator hauv cov txheej txheem kuaj mob, suav nrog kev kuaj pom myocardial perfusion thiab kuaj kev ntxhov siab, qhov uas nws pab ntsuas kev ua haujlwm ntawm cov hlab ntsha. Hauv kev tshawb fawb tshuaj, dypyridamole yog siv los ua qhov sib xyaw ua ke rau kev tshuaj xyuas cov tshuaj tiv thaiv kab mob tshiab, tshawb nrhiav cov txheej txheem ntawm platelet inhibition, thiab kawm cov tshuaj cuam tshuam nrog cyclic nucleotide txoj hauv kev.
Cov txiaj ntsig
Cov txiaj ntsig ntawm dypyridamole yog ze ze nrog nws cov khoom siv tshuaj ntau yam, kev nyab xeeb, thiab kev ua haujlwm zoo. Nws inhibits platelet aggregation los ntawm kev nce intracellular cyclic AMP thiab txo cov thromboxane ntau lawm, muab kev tiv thaiv los ntawm cov ntshav txhaws. Nws cov vasodilatory kev ua haujlwm txhim kho microcirculation, txhim kho cov ntaub so ntswg perfusion thaum kuaj cov txheej txheem thiab kev siv kho mob. Dypyridamole qhia pom qhov zoo ntawm qhov ncauj bioavailability, tswj cov tshuaj pharmacokinetics, thiab kev sib raug zoo nrog lwm cov tshuaj kho plawv, ua rau nws tsim nyog rau kev sib xyaw ua ke. Nws zoo -tus yam ntxwv ntawm kev ua haujlwm thiab tsim keeb kwm kev kho mob muab kev ntseeg siab hauv ob qho tib si kev tshawb fawb thiab kev kho mob, txhawb nqa cov txiaj ntsig tau rov ua dua thiab kwv yees tau.
Xaus
Dypyridamole yog ntau yam kab mob plawv nrog kev siv dav hauv kev tiv thaiv thrombosis, vasodilation, thiab kev tshawb fawb tshuaj. Nws ob lub luag haujlwm ua platelet inhibitor thiab vasodilator, ua ke nrog cov pov thawj ua tau zoo thiab kev nyab xeeb, ua rau nws yog ib qho tseem ceeb hauv kev kho mob thiab kev tsim tshuaj. Los ntawm kev ua kom cov ntshav khiav tau zoo, tiv thaiv cov xwm txheej thromboembolic, thiab txhawb kev tshawb fawb txog plawv, dypyridamole tseem ua lub luag haujlwm tseem ceeb hauv cov tshuaj niaj hnub thiab kev tshawb fawb biomedical.
Cim npe nrov: dypyridamole 丨cas 58-32-2, Tuam Tshoj dypyridamole 丨cas 58-32-2 manufacturers, lwm tus neeg, Hoobkas
